« Back to Record
Kudo, M., Finn, R. R., Edeline, J., Cattan, S., Ogasawara, S., Palmer, D. D., Verslype, C., Zagonel, V., Fartoux, L., Vogel, A., Sarker, D., Verset, G., Chan, S. L., Knox, J., Daniele, B., Yau, T., Gurary, E. E., Siegel, A. A., Wang, A., Cheng, A. L., & Zhu, A. X. (2022). Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. European journal of cancer, 167, 1-12. doi:10.1016/j.ejca.2022.02.009
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/342427



